Inventor · disambiguated record
Sheng-Bin Peng
Also filed as: PENG SHENG-BIN
9 granted patents·6 pending applications·150 citations·filing 2002–2023
86Inventor score
Top patents by PatentIndex Score
15 records- 0197US9187474B2Raf inhibitor compoundsDECIPHERA PHARMACEUTICALS LLC·Filed 2013·Granted Nov 17, 2015·60 cites·19 claims
- 0295US9334267B2RAF inhibitor compoundsDECIPHERA PHARMACEUTICALS LLC·Filed 2013·Granted May 10, 2016·60 cites·17 claims
- 0385US6951840B2Lipoglycopeptide antibioticsLILLY CO ELI·Filed 2002·Granted Oct 4, 2005·23 cites·3 claims
- 0481US10968214B2KRas G12C inhibitorsLILLY CO ELI·Filed 2019·Granted Apr 6, 2021·2 cites·26 claims
- 0578US7892546B2Anti-CXCR4 antibodiesLILLY CO ELI·Filed 2009·Granted Feb 22, 2011·2 cites·10 claims
- 0675USRE42274ECyclic peptide CXCR4 antagonistsLILLY CO ELI·Filed 2010·Granted Apr 5, 2011·3 cites·14 claims
- 0769US2023339968A1KRAS Gl2C INHIBITORSLILLY CO ELI·Filed 2023·Application pending·0 cites
- 0861US11731984B2KRas G12C inhibitorsLILLY CO ELI·Filed 2020·Granted Aug 22, 2023·0 cites·23 claims
- 0961US2024108618A1Kras g12c inhibitor dosing regimensLILLY CO ELI·Filed 2023·Application pending·0 cites
- 1061US2025177389A1Method of treatment including kras g12c inhibitors and shp2 inhibitorsLILLY CO ELI·Filed 2023·Application pending·0 cites
- 1161US2025249019A1Method of treatment including kras g12c inhibitors and aurora a inhibitorsLILLY CO ELI·Filed 2023·Application pending·0 cites
- 1259US7691813B2Cyclic peptide CXCR4 antagonistsLILLY CO ELI·Filed 2008·Granted Apr 6, 2010·0 cites·14 claims
- 1357US8003102B2Anti-CXCR4 antibodiesLILLY CO ELI·Filed 2010·Granted Aug 23, 2011·0 cites·2 claims
- 1457US2025228848A1Process for making a kras g12c inhibitorLILLY CO ELI·Filed 2023·Application pending·0 cites
- 1545US2010130409A1Cyclic peptide cxcr4 antagonistsLILLY CO ELI·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sheng-Bin Peng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →